Flu Vaccine Decision Maker Cancelled Without Explanation
The cancellation of the FDA's vaccine advisory meeting without explanation raises concerns about the impact on flu shot selection for next season, particularly with a record-breaking flu season already underway. The decision comes as RFK Jr., a vocal vaccine skeptic now leading the Department of Health and Human Services, makes early moves that could affect vaccination uptake and policy in the U.S. The cancellation also underscores the lack of transparency in the meeting's cancellation.
- This move highlights the vulnerability of critical decision-making processes within government agencies to new leadership and changing priorities.
- What will be the consequences for public health if the FDA is unable to establish a consistent and evidence-based process for selecting flu strains, and who bears the responsibility for this failure?